Skip to content

Released Aug 15, 2011, during market hours

10-Q filed Aug 15, 2011, 46 days after period end · 0001144204-11-047055

Q2 2011 · 10-Q
Revenue—
Net Income-$6.76KN/M vs Q2 2010N/M vs Q1 2011
EPS Diluted$0.00— vs Q2 2010no prior Q1 2011 on file
Operating Income-$5,862N/M
Operating Cash Flowderived-$15,404—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2011Q2 2010
Net Income-$6.76K-$5.58K
EPS Diluted$0.00$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR